FUL:NYE-H. B. Fuller Company (USD)

EQUITY | Specialty Chemicals | New York Stock Exchange

Last Closing

USD 77.38

Change

0.00 (0.00)%

Market Cap

USD 2.42B

Volume

0.27M

Analyst Target

USD 50.83
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

H.B. Fuller Company is a formulator, manufacturer and marketer of adhesives, sealants, paints and other specialty chemical products. Its products include H.B. Fuller, Swift, Advantra, Clarity, Sesame, TEC, Foster, Rakoll and Rapidex.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-15 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap
SHW Sherwin-Williams Co

N/A

USD 76.38B
ECL Ecolab Inc

N/A

USD 69.68B
APD Air Products and Chemicals Inc

N/A

USD 60.67B
DD Dupont De Nemours Inc

N/A

USD 33.62B
LYB LyondellBasell Industries NV

N/A

USD 30.46B
PPG PPG Industries Inc

N/A

USD 29.86B
DLY DoubleLine Yield Opportunities..

N/A

USD 27.84B
IFF International Flavors & Fragra..

N/A

USD 24.51B
WLK Westlake Chemical Corporation

N/A

USD 19.02B
AVTR Avantor Inc

N/A

USD 15.03B

ETFs Containing FUL

PSCM Invesco S&P SmallCap Mate.. 0.00 % 0.29 %

N/A

USD 0.02B

Market Performance

  Market Performance vs. Industry/Classification (Specialty Chemicals) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.95% 38% F 24% F
Dividend Return 0.53% 27% F 22% F
Total Return -4.43% 38% F 23% F
Trailing 12 Months  
Capital Gain 15.82% 67% D+ 75% C
Dividend Return 1.25% 35% F 17% F
Total Return 17.07% 65% D 72% C
Trailing 5 Years  
Capital Gain 77.76% 84% B 81% B-
Dividend Return 8.27% 30% F 29% F
Total Return 86.04% 81% B- 80% B-
Average Annual (5 Year Horizon)  
Capital Gain 17.21% 71% C- 82% B
Dividend Return 18.46% 71% C- 81% B-
Total Return 1.24% 37% F 29% F
Risk Return Profile  
Volatility (Standard Deviation) 28.56% 65% D 37% F
Risk Adjusted Return 64.61% 92% A 84% B
Market Capitalization 2.42B 57% F 74% C

Key Financial Ratios

  Ratio vs. Industry/Classification (Specialty Chemicals) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 22.30 33% 26%
Price/Book Ratio 2.34 47% 36%
Price / Cash Flow Ratio 10.97 48% 35%
Price/Free Cash Flow Ratio 10.74 44% 39%
Management Effectiveness  
Return on Equity 9.06% 58% 54%
Return on Invested Capital 7.63% 57% 56%
Return on Assets 5.55% 60% 76%
Debt to Equity Ratio 104.64% 31% 34%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.